Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1

Sanam Loghavi, Naveen Pemmaraju, Rashmi Kanagal-Shamanna, Meenakshi Mehrotra, L. Jeffrey Medeiros, Raja Luthra, Pei Lin, Yang Huh, Hagop M. Kantarjian, Jorge E. Cortes, Srdan Verstovsek, Keyur P. Patel

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)3360-3363
Number of pages4
JournalBlood
Volume125
Issue number21
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Cite this

Loghavi, S., Pemmaraju, N., Kanagal-Shamanna, R., Mehrotra, M., Medeiros, L. J., Luthra, R., ... Patel, K. P. (2015). Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1. Blood, 125(21), 3360-3363. https://doi.org/10.1182/blood-2015-03-632893

Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1. / Loghavi, Sanam; Pemmaraju, Naveen; Kanagal-Shamanna, Rashmi; Mehrotra, Meenakshi; Medeiros, L. Jeffrey; Luthra, Raja; Lin, Pei; Huh, Yang; Kantarjian, Hagop M.; Cortes, Jorge E.; Verstovsek, Srdan; Patel, Keyur P.

In: Blood, Vol. 125, No. 21, 01.01.2015, p. 3360-3363.

Research output: Contribution to journalLetter

Loghavi, S, Pemmaraju, N, Kanagal-Shamanna, R, Mehrotra, M, Medeiros, LJ, Luthra, R, Lin, P, Huh, Y, Kantarjian, HM, Cortes, JE, Verstovsek, S & Patel, KP 2015, 'Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1', Blood, vol. 125, no. 21, pp. 3360-3363. https://doi.org/10.1182/blood-2015-03-632893
Loghavi S, Pemmaraju N, Kanagal-Shamanna R, Mehrotra M, Medeiros LJ, Luthra R et al. Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1. Blood. 2015 Jan 1;125(21):3360-3363. https://doi.org/10.1182/blood-2015-03-632893
Loghavi, Sanam ; Pemmaraju, Naveen ; Kanagal-Shamanna, Rashmi ; Mehrotra, Meenakshi ; Medeiros, L. Jeffrey ; Luthra, Raja ; Lin, Pei ; Huh, Yang ; Kantarjian, Hagop M. ; Cortes, Jorge E. ; Verstovsek, Srdan ; Patel, Keyur P. / Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1. In: Blood. 2015 ; Vol. 125, No. 21. pp. 3360-3363.
@article{fb0a42444c2e4951ab4ffd03d0b0b6a4,
title = "Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1",
author = "Sanam Loghavi and Naveen Pemmaraju and Rashmi Kanagal-Shamanna and Meenakshi Mehrotra and Medeiros, {L. Jeffrey} and Raja Luthra and Pei Lin and Yang Huh and Kantarjian, {Hagop M.} and Cortes, {Jorge E.} and Srdan Verstovsek and Patel, {Keyur P.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1182/blood-2015-03-632893",
language = "English (US)",
volume = "125",
pages = "3360--3363",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "21",

}

TY - JOUR

T1 - Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1

AU - Loghavi, Sanam

AU - Pemmaraju, Naveen

AU - Kanagal-Shamanna, Rashmi

AU - Mehrotra, Meenakshi

AU - Medeiros, L. Jeffrey

AU - Luthra, Raja

AU - Lin, Pei

AU - Huh, Yang

AU - Kantarjian, Hagop M.

AU - Cortes, Jorge E.

AU - Verstovsek, Srdan

AU - Patel, Keyur P.

PY - 2015/1/1

Y1 - 2015/1/1

UR - http://www.scopus.com/inward/record.url?scp=84964694696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964694696&partnerID=8YFLogxK

U2 - 10.1182/blood-2015-03-632893

DO - 10.1182/blood-2015-03-632893

M3 - Letter

C2 - 25999449

AN - SCOPUS:84964694696

VL - 125

SP - 3360

EP - 3363

JO - Blood

JF - Blood

SN - 0006-4971

IS - 21

ER -